Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McCaw

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Plos Genetics|August 30, 2021
Multitrait GWAS to connect disease variants and biological mechanismsHanna Julienne, Vincent Laville, Zachary R McCaw, et al.
Nature Genetics|July 8, 2024
Unsupervised representation learning on high-dimensional clinical data improves genomic discovery and predictionTaedong Yun, Justin Cosentino, Babak Behsaz, et al.
BMJ Oncology|January 31, 2025
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trialsAlexander D Sherry, Pavlos Msaouel, Timothy A Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Unsupervised representation learning improves genomic discovery and risk prediction for respiratory and circulatory functions and diseasesTaedong Yun, Justin Cosentino, Babak Behsaz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology TrialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
NPJ Precision Oncology|July 24, 2025
Survival-inferred fragility of statistical significance in phase III oncology trialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor TrialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Plos Genetics|August 30, 2021
Multitrait GWAS to connect disease variants and biological mechanismsHanna Julienne, Vincent Laville, Zachary R McCaw, et al.
Nature Genetics|July 8, 2024
Unsupervised representation learning on high-dimensional clinical data improves genomic discovery and predictionTaedong Yun, Justin Cosentino, Babak Behsaz, et al.
BMJ Oncology|January 31, 2025
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trialsAlexander D Sherry, Pavlos Msaouel, Timothy A Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Unsupervised representation learning improves genomic discovery and risk prediction for respiratory and circulatory functions and diseasesTaedong Yun, Justin Cosentino, Babak Behsaz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology TrialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
NPJ Precision Oncology|July 24, 2025
Survival-inferred fragility of statistical significance in phase III oncology trialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor TrialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Pageof 15